Live from the NIH registry
Studies recruiting near Danbury right now
Top 25 of 1,191 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Mount Kisco, New York (19.0 mi)
· Sponsor: Medtronic
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Yale University (Adults and Pediatrics) — New Haven, Connecticut (28.9 mi)
· Sponsor: Pierre Fabre Medicament
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
New York Medical College — Valhalla, New York (27.6 mi)
· Sponsor: New York Medical College
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (28.9 mi)
· Sponsor: Genentech, Inc.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Smilow Cancer Hospital (Yale University) — New Haven, Connecticut (28.9 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
New York Medical College — Valhalla, New York (27.6 mi)
· Sponsor: National Cancer Institute (NCI)
Speech Motor Learning and Retention (Aim 3)
Speech
N/A
Interventional 50 participants sought
Yale Child Study Center — New Haven, Connecticut (28.9 mi)
· Sponsor: Yale University
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Takeda
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0117 — New Haven, Connecticut (28.9 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
New York Medical College at Westchester Medical Center — Valhalla, New York (27.6 mi)
· Sponsor: Anagram Therapeutics, Inc.
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (29.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Opioid Use Disorder, OAT
Phase 1
Interventional 110 participants sought
Connecticut Mental Health Center, Clinical Neuroscience Research Unit — New Haven, Connecticut (28.9 mi)
· Sponsor: Yale University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — New Haven, Connecticut (28.9 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Parkinson's Disease
Phase 1
Interventional 124 participants sought
Institute for Neurodegenerative Disorders — New Haven, Connecticut (28.9 mi)
· Sponsor: Prevail Therapeutics
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Open Surgery, Lymphedema
N/A
Observational 455 participants sought
Yale New Haven Hospital — New Haven, Connecticut (28.9 mi)
· Sponsor: MMI (Medical Microinstruments, Inc.)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Kura Oncology, Inc.
Psilocybin as a Treatment for Chronic Pain in Smokers
Smokers With Chronic Pain
EARLY/Phase 1
Interventional 10 participants sought
Department of Veterans Affairs — West Haven, Connecticut (28.6 mi)
· Sponsor: Yale University
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 2
Interventional 180 participants sought
Yale University School of Medicine /ID# 278181 — New Haven, Connecticut (28.9 mi)
· Sponsor: AbbVie
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — New Haven, Connecticut (28.9 mi)
· Sponsor: Normunity AccelCo, Inc.
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
Yale Cancer Center — New Haven, Connecticut (28.9 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
New England Institute for Clinical Research (Ki Health Partners) — Stamford, Connecticut (24.3 mi)
· Sponsor: Annovis Bio Inc.
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 121 participants sought
Yale University — New Haven, Connecticut (28.9 mi)
· Sponsor: Genmab
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8
Phase 2
Interventional 16 participants sought
Yale University Cancer Center LAO — New Haven, Connecticut (28.9 mi)
· Sponsor: National Cancer Institute (NCI)